News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ellipse Technologies, Inc. Completes Enrollment for the Initial Clinical Trial of the MAGEC Remote Control, Non-Invasive System for the Treatment of Scoliosis


7/15/2010 12:17:10 PM

IRVINE, Calif.--(BUSINESS WIRE)--Ellipse Technologies, Inc. (“Ellipse”) announced it had completed the initial clinical study enrollment for its MAGECTM (MAGnetic Expansion Control) Technology in “At Risk Early Onset Scoliosis Patients.”

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES